- Home
- TGL vs PLRZ Comparison
TGL vs PLRZ Comparison
Compare TGL & PLRZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TGL
- PLRZ
- Stock Information
- Founded
- TGL 2020
- PLRZ 2005
- Country
- TGL United States
- PLRZ Israel
- Employees
- TGL N/A
- PLRZ N/A
- Industry
- TGL Retail: Computer Software & Peripheral Equipment
- PLRZ
- Sector
- TGL Technology
- PLRZ
- Exchange
- TGL Nasdaq
- PLRZ NYSE
- Market Cap
- TGL 4.1M
- PLRZ 3.7M
- IPO Year
- TGL 2022
- PLRZ 2024
- Fundamental
- Price
- TGL $1.29
- PLRZ $1.54
- Analyst Decision
- TGL
- PLRZ
- Analyst Count
- TGL 0
- PLRZ 0
- Target Price
- TGL N/A
- PLRZ N/A
- AVG Volume (30 Days)
- TGL 371.9K
- PLRZ 16.0M
- Earning Date
- TGL 08-25-2025
- PLRZ 02-15-2025
- Dividend Yield
- TGL N/A
- PLRZ N/A
- EPS Growth
- TGL N/A
- PLRZ N/A
- EPS
- TGL N/A
- PLRZ N/A
- Revenue
- TGL $1,468,790.00
- PLRZ N/A
- Revenue This Year
- TGL N/A
- PLRZ N/A
- Revenue Next Year
- TGL N/A
- PLRZ N/A
- P/E Ratio
- TGL N/A
- PLRZ N/A
- Revenue Growth
- TGL N/A
- PLRZ N/A
- 52 Week Low
- TGL $1.01
- PLRZ $0.55
- 52 Week High
- TGL $116.00
- PLRZ $1,200.00
- Technical
- Relative Strength Index (RSI)
- TGL 56.95
- PLRZ N/A
- Support Level
- TGL $1.05
- PLRZ N/A
- Resistance Level
- TGL $1.14
- PLRZ N/A
- Average True Range (ATR)
- TGL 0.09
- PLRZ 0.00
- MACD
- TGL 0.03
- PLRZ 0.00
- Stochastic Oscillator
- TGL 83.87
- PLRZ 0.00
About TGL Treasure Global Inc.
Treasure Global Inc has created an online-to-offline e-commerce platform business model offering consumers and merchants instant rebates and affiliate cashback programs, while providing a seamless e-payment solution with rebates in both e-commerce and physical retailers/merchant settings. Its product is an internet application branded ZCITY app, that targets consumers by providing personalized deals based on consumers' purchase history, location and preferences.
About PLRZ POLYRIZON LTD
Polyrizon Ltd is a clinical development stage biotech company specializing in the development of nasal gels to provide preventative treatment to protect against a wide cross-section of viruses, including certain variants of COVID-19 that are also considered to cause more infections and spread faster than the original strain of the virus (the CDC expects that additional variants of the virus will continue to occur), influenza, allergens, and other toxins. Its technology platforms are Capture & Contain and Trap & Target.